Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-23
1990-09-04
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514538, 514539, 514542, 514562, 514604, 514605, 548253, 560 12, 560 13, 562430, 564 82, A61K 3118, C07C14374, C07C14380
Patent
active
049545132
ABSTRACT:
This invention relates to alkanoic acid compounds having phenyl and heteroarylthio substituents which are useful as leukotriene antagonists, pharmaceutical compositions containing such compounds, and methods of treating diseases in which leukotrienes are a factor by administration of an effective amount of the above compounds or compositions.
REFERENCES:
patent: 66588 (1987-06-01), Frazee et al.
patent: 66592 (1987-06-01), Gleason et al.
patent: 4609744 (1986-09-01), Young et al.
Chemical Abstracts, vol. 101, No. 17, p. 718, Abstract 151857q (Oct. 22, 1984).
Patent Abstracts of Japan, vol. 9, No. 306 (C-317) (2029) Dec. 3, 1985.
Derwent Patent Abstract 84-014267/03 of Japanese Patent Application 58206556A published Dec. 1, 1983.
Chemical Abstracts 96(17):143290n.
Chemical Abstracts 94(9):64755y.
Chemical Abstracts, vol. 96, 98909h (1982).
Gleason et al., J. Med. Chem., 30, 6, 959-961 (1987).
Gleason John G.
Hall Ralph F.
Smallheer Joanne
Kanagy James M.
Lentz Edward T.
Shippen Michael L.
SmithKline Beecham Corporation
Suter Stuart R.
LandOfFree
Leukotriene antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-442320